A Phase I, Single Centre, Randomised, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of a Single Dose and Multiple Doses of TC-5214 (S-Mecamylamine) in Healthy Male Japanese Subjects
Phase of Trial: Phase I
Latest Information Update: 05 Feb 2013
At a glance
- Drugs Dexmecamylamine (Primary)
- Indications Anxiety disorders; Depression
- Focus Adverse reactions
- 07 Dec 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 07 Dec 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 18 Aug 2010 New trial record